Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 525 of 1463 entries
View as:

Effect of Prebiotics on Blood Glucose Management

Phase: N/A Priority: Normal
NCT ID: NCT04636489 Org: User:
Start: 11/30/20 End: 12/31/24 Due: 12/31/25

Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23)

Phase: N/A Priority: Normal
NCT ID: NCT07032532 Org: User:
Start: 07/31/25 End: 12/31/28 Due: 12/31/29

REal-world Data of CARdiometabolic ProtEcTion

Phase: N/A Priority: Normal
NCT ID: NCT07038083 Org: User:
Start: 01/01/14 End: 01/01/44 Due: 01/01/45

Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02871518 Org: User:
Start: 08/31/16 End: 07/31/21 Due: 07/31/22

Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00262327 Org: User:
Start: 05/31/05 End: 02/28/06 Due: 02/28/07

Study of Tumor Infiltrating Lymphocytes Following CCRT in the Treatment of Patients With Cervical Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04443296 Org: User:
Start: 10/12/19 End: 12/31/22 Due: 12/31/23

Screening and Identifying Hepatobiliary Diseases Via Deep Learning Using Ocular Images

Phase: N/A Priority: Normal
NCT ID: NCT04213183 Org: User:
Start: 12/01/18 End: 01/31/20 Due: 01/31/21

Effectiveness of Using Interactive Consulting System to Enhance Informed Choice

Phase: N/A Priority: Normal
NCT ID: NCT04246346 Org: User:
Start: 09/01/23 End: 12/31/23 Due: 12/31/24

Human Umbilical Cord Mesenchymal Stem Cells (MSCs) Therapy in ARDS

Phase: N/A Priority: Normal
NCT ID: NCT03608592 Org: User:
Start: 06/01/18 End: 12/01/20 Due: 12/01/21

Omitting CTV for Primary Tumor in LS-SCLC

Phase: N/A Priority: Normal
NCT ID: NCT07008716 Org: User:
Start: 06/03/25 End: 12/31/32 Due: 12/31/33

High Dose Radiotherapy for the Treatment of Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03541304 Org: User:
Start: 01/01/17 End: 12/16/21 Due: 12/16/22

Interventional Radiology for the Treatment of Symptomatic Portal Hypertension in Patients With Cavernous Transformation of Portal Vein

Phase: N/A Priority: Normal
NCT ID: NCT02504034 Org: User:
Start: 10/31/10 End: - Due: -

Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00842647 Org: User:
Start: 07/31/06 End: 08/31/09 Due: 08/31/10

Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT01528488 Org: User:
Start: 12/31/11 End: 07/31/13 Due: 07/31/14

High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)

Phase: N/A Priority: Normal
NCT ID: NCT06646211 Org: User:
Start: 01/01/25 End: 01/01/28 Due: 01/01/29

Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis

Phase: N/A Priority: Normal
NCT ID: NCT01350206 Org: User:
Start: 04/30/10 End: 05/31/13 Due: 05/31/14

Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04844385 Org: User:
Start: 02/20/21 End: 12/20/24 Due: 12/20/25

Evaluation of WGc-043 Injection in Advanced Solid Tumors: Phase I Study

Phase: N/A Priority: Normal
NCT ID: NCT07028047 Org: User:
Start: 06/23/25 End: 06/30/28 Due: 06/30/29

Toripalimab and Anlotinib Combination Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma After Failure of at Least One Line of Platinum-Based Chemotherapy (TORAL)

Phase: N/A Priority: Normal
NCT ID: NCT04996758 Org: User:
Start: 10/30/21 End: 12/01/24 Due: 12/01/25

Early Intervention Program for Children With Autism (BCRI Model)

Phase: N/A Priority: Normal
NCT ID: NCT00819364 Org: User:
Start: 08/31/09 End: 08/31/16 Due: 08/31/17

Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma

Phase: N/A Priority: Normal
NCT ID: NCT01649830 Org: User:
Start: 07/31/12 End: 08/31/26 Due: 08/31/27

Umbrella Biomarker-Guided Therapy in NPC

Phase: N/A Priority: Normal
NCT ID: NCT04605562 Org: User:
Start: 06/30/22 End: 12/31/26 Due: 12/31/27

Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03244358 Org: User:
Start: 03/01/17 End: 12/01/20 Due: 12/01/21

Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT00762346 Org: User:
Start: 09/30/08 End: 03/31/13 Due: 03/31/14

The Investigation of Knowledge and Educational Demand of Sexual and Reproductive Health Among Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT05817981 Org: User:
Start: 05/31/23 End: 03/31/24 Due: 03/31/25